marcos maldaun

Neurosurgical Oncologist

[marcos maldaun @maldaun]

Snola 2026 is coming ... https://t.co/Nz47tIjnwf

[Nature Medicine @NatureMedicine]

MethyLYZR, an epigenetic classifier of brain tumors, provides clinically relevant cancer classification results within 15 minutes of sequencing, with potential applications for neurosurgical intraoperative use

https://t.co/KrlAmkjXzh

[EANO @EANOassociation]

An article discussing development and validation of a molecular classifier of meningiomas is now available in Neuro-Oncology. 👉 https://t.co/Qz6WY8T1HL #EANOessentials #NeuroOncology #Meningioma

[National Brain Tumor Society @NBTStweets]

Exciting News! Vorasidenib (brand name: Voranigo) has just been approved by the FDA for the treatment of adult and pediatric patients 12 years of age and older with grade 2 astrocytoma or oligodendroglioma with an IDH1 or IDH2 mutation. Read more: https://t.co/G6FB95R7nj

[Brain Pathology @brainpathol]

Refinement of prognostication for IDH-mutant #astrocytomas using DNA methylation-based classification
#neuropath #braintumor
https://t.co/oxMwrJMQaO

[marcos maldaun @maldaun]

The largest Neuro-oncology meeting in Latam is coming...amazing international and national speakers
Most relevent subjects in NO field covered
https://t.co/ggswUjoPN5

[SNO @NeuroOnc]

The INDIGO trial: Precision medicine finally comes to glioma
https://t.co/QZucCOHe14

[Journal of Neuro-Oncology @JNeurooncol]

Glioma growth involving language-eloquent centers in the brain may alter language networks. In their study, Chang et al. found various patient and radiographic characteristics in glioma patients to be associated with preoperative language performance. https://t.co/vs5f4R9qEF

[Journal of Neuro-Oncology @JNeurooncol]

Is there a role for liquid biopsies in CSF in treating CNS metastases from breast cancer? Check out this recent study in #JNO to learn about how genetic alterations can be identified in CSF samples to guide targetable treatment for these patients. https://t.co/KUp8MwTORu

[marcos maldaun @maldaun]

@cafecomferri Wiplash em busca da perfeição

[EANO @EANOassociation]

Cerebrospinal fluid methylome-based liquid biopsies for accurate malignant brain neoplasm classification.
https://t.co/umj2POcfl8
#btsm @NeuroOnc

[marcos maldaun @maldaun]

@gugachacra Opa,
Tele ganhou 2 mundiais … logo muito maior que Abel. Nessa nem DataFolha te ajuda

[Armin Mortazavi @arminm870]

One out of three patients with gliomas suffer from medically refractory epilepsy. Our paper discusses how IDH-mutant gliomas promote neuronal excitability through D-2-HG mediated mTOR hyperactivation, a potential therapeutic target for these patients. https://t.co/KgMsilAbgI

[EANO @EANOassociation]

#EGFR, the Lazarus target for precision oncology in #glioblastoma.
https://t.co/sb4lt8hcDw
#btsm @NeuroOnc

[marcos maldaun @maldaun]

@plihalespn @gugachacra

[marcos maldaun @maldaun]

@gugachacra Por que tanto ódio ?
“Minha história é sua obsessão ???”

[marcos maldaun @maldaun]

@CaioResenha

[marcos maldaun @maldaun]

@gugachacra #Semmundial; #birebaixado #pabloqualéamusica

[Springer Med Books @SpringerClinMed]

New! Intraoperative Monitoring provides cutting-edge information in the field of IOM, and highlights new neurophysiological tools being used in various surgeries.
#anatomicaloverview #electricalsafety, #neurophysiologicaltests
https://t.co/9LLQ3e17Ex

[Martin ZapataLaguado @zapatalaguadomd]

Great opportunities in this indications! 🦾🦾⁦@EANOassociation⁩ ⁦@NeuroOnc⁩ ⁦@SNOLAsociety⁩ hope in LATAM got a quick approbation as well!